In this educational session, explore how virtual clinical trials and bio-simulations can make pharmacovigilance departments an integral part of the drug development process, reducing regulatory and financial risk for pharmaceutical companies.
- Conceptualize how to conduct virtual clinical trials for a drug in development, which could improve its use in different populations based on its pharmacological profile.
- Understand how to conduct virtual medication safety studies in populations typically excluded from traditional clinical trials.
- Recognize the risk of medication-related problems for certain patient populations and drug regimens.
- Conceptualize a virtual clinical trial that helps compare drugs within the same class or with a similar indication.
